Consistent with animal studies, immunoblotting analysis of liver tissues obtained from HCC patients indicated higher levels of PAK4, total-, phospho-, and nuclear-NCoR1, and lower levels of HMGCS2 in tumor compared to non-tumorous tissues (Fig. 7c and Supplementary Fig. 10c, d). This evidence concerns the gene HMGCS2 and hepatocellular carcinoma.